Under construction – not a live service
Sign in
Taking people in United KingdomNo phase

Remote Monitoring to Detect Early Flare-ups of COPD

Tests a bedside device that tracks body signals during sleep in adults with COPD.

Plain-language title generated from the registry record
Registry title: Non-contact Proactive Remote Monitoring of COPD Exacerbations

Key facts

Where
London, United KingdomSee the site

Where in United Kingdom

  • Royal Free HospitalLondon, United KingdomTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Life Detection Technologies
Trial code
NCT05598983
Record updated
24 March 2025
Original description
The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are:Read full original descriptionShow less

Non-contact Proactive Remote Monitoring to Facilitate Early Detection of Exacerbations in Chronic Obstructive Pulmonary Disease (COPD)

The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are:

* Can an exacerbation be detected before the person recognizes they are unwell? * What are the biological signals which provide the best indication of decompensation? * How does this indication of decompensation compare to a daily CAT?

Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.

Inclusion: Confirmed diagnosis of COPD; 1 or more exacerbation in the last year; Aged over 18 years; Willing to use monitoring devices and complete study questionnaires; Adequate English; Signed consent form.

Exclusion: Pregnancy; BMI greater than 45 kg/m2; Nil other, provided inclusion criteria are met.

ClinicalTrials.gov NCT05598983